NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives

NY-ESO-1 or New York esophageal squamous cell carcinoma 1 is a well-known cancer-testis antigen (CTAs) with re-expression in numerous cancer types. Its ability to elicit spontaneous humoral and cellular immune responses, together with its restricted expression pattern, have rendered it a good candid...

Descripción completa

Detalles Bibliográficos
Autores principales: Thomas, Remy, Al-Khadairi, Ghaneya, Roelands, Jessica, Hendrickx, Wouter, Dermime, Said, Bedognetti, Davide, Decock, Julie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5941317/
https://www.ncbi.nlm.nih.gov/pubmed/29770138
http://dx.doi.org/10.3389/fimmu.2018.00947

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5941317/
https://www.ncbi.nlm.nih.gov/pubmed/29770138
http://dx.doi.org/10.3389/fimmu.2018.00947

Ejemplares similares